Led a team of Market Access, Public/Government Affairs, Pricing and Sustainability (Health Equity, Environmental impact) for the APAC region. Key therapeutic areas include : Diabetes, Obesity, Cardiovascular Diseases, Rare Diseases Develop and manage the right organisational structure, talents, capacity and capabilities in the countries.

Created the very first course on Market Access, specifically for MedTech.

Regularly invited to exchange on Digital Health, Market Access, Health Data, Health Policy, Reimbursement and Health Technology Assessment (HTA). At major international conferences, such as Frontiers Health, Asia Digital Healthcare Innovation Summit, Hello Tomorrow, SEMI Global Smart MedTech Symposium, APACMEd MedTech Forum, NUS Biobiz...

Lead strategy & implementation of Industry Access Policy Shaping initiatives in Digital Health, Precision Medicine and Diagnostics

Established the Market Access function in the Abbott Rapid Diagnostics Emerging Markets organisation, in Asia-Pacific. Led the Regional Market Access strategy and develop country team capabilities, to deliver optimal value capture & funding, though policy shaping & advocacy to expand the market in the long term. • Initiated an industry-wide advocacy for the value of diagnostics and decentralised screening to APAC policy-makers (2 position papers, ASEAN workshops with policy-makers, collaboration a Ministry of Health on its Diagnostics infrastructure)• Developed the very first APAC decision-maker network program to shape policies & guidelines for a new product launch (policy makers, funders, implementers, NGOs, patient groups, advocacy groups, community groups...)• Created APAC Market Access organizational structure, growing from individual contributor to 5 headcounts, and upskilled the organization's capabilities

Led the Industry group's foundational efforts in shaping policies for a more fit-for-purpose evaluation and better patient access to Digital Health Technologies. 4 papers published and 10+ webinars regionally and in-country:1/ identifying market access & reimbursement landscape and gaps2/ monetization models best practices3/ global overview on Health Technology Assessment framworks for Digital Health 4/ Position paper on Value Assessment and funding & reimbursement frameworks for Policy makers & Payers in ASPAC

Solution-focused to deliver health innovations to patients, value-based healthcare (VBHC) to providers & payers.Responsible for the Asia-Pacific Market Access & Health Economics strategy and economic value proposition, including HTA, reimbursement, tenders and funding activities for Orthopedics & Biosurgery, providing strategic insights into innovation pipeline, accelerate Market Access.Drives clinical & economic Evidence Generation Strategy, to generate and disseminate differentiated evidence to enable Access & AdoptionChair APACMed Digital Health Reimbursement Workgroup: https://apacmed.org/our-work/digital-health/

Global Orthopedics, Depuy Synthes

Develops, implements Market Access, Health Economics & Outcomes Research and Reimbursement strategies across the Asia Pacific Region.

Immunology (Rheumatology, Psoriasis / Dermatology, Inflammatory Bowel Diseases), Gastroenterology, Psychiatry, ....• Lead effective, multi-channel, evidence-based scientific external education & communication strategy and their operational implementation in Therapeutic Areas above, including measuring their impact & healthcare outcomes • Developed creative approaches for in-depth, direct understanding of stakeholder perspectives(Patients, Payers, Patients workshops) to shape meaningful clinical & educational strategies• Real World Evidence data mining in immunology to improve product value proposition• Provided internal scientific trainings, conducted and chaired external meetings• Participated in protocol design and publication development of clinical studies• Engagement & collaboration with international Key Opinion Leaders, and partnerships with medical professional organizations • Close collaboration with Regional Medical Affairs and Marketing Directors, and other functions.• Support country affiliates in Asia-Pacific to improve internal Medical Education capabilities, and to implement regional programs locally.• Digital Strategy Lead, Individual Leadership Award, 2 consecutive annual Awards for Excellence in regional initiatives

Market analysis of Medical Devices containing nanomaterialsLead a multidisciplinary board of experts to reach a consensus on recommendations for safety regulationReviewed the Regulatory framework for Medical Devices containing nanomaterialsEstablished a scientific report and regulatory guidelines for the biological risk assesmment of Medical Devices incorporating nanomaterials.

Expertise: Psoriasis (biotherapy), Neurology-Geriatrics, PsychiatryManaged and lauched 4 Medical Education programs, 10 conferences/symposiaDevised and implemented new validation and archiving procedures (hard and soft copies)Planned, developed and managed Medical Education programs and scientific communications projects in neurosciences and dermatology (immunology).Coordinated & drove their implementation in France with the Medical, Marketing, Regulatory Affairs.Represented France and liaise with European Medical Education teams.Established and managed an external network of support agencies and Key Opinion Leaders (Public Relations) in order to develop appropriate medical content in line with the product strategy (Stelara, Reminyl, Risperdal Consta).

Thesis: Synthesis and biological assessment of bioactive organometallic derivatives for diagnosis and therapy of breast cancer3 collaborations, 4 publications in international peer-reviewed journals, 5 oral communications with 1 prize, 3 postersSharpened my organizational, analytical and problem-solving skills during my research project . Initiated many collaborations (national and international) in different scientific areas. Supervisor: Prof. Gérard Jaouen, at the Laboratory of Organometallic Chemistry & Biochemistry